ABVC BioPharma, Inc. (ABVC) vs Aligos Therapeutics, Inc. (ALGS)
ABVC BioPharma, Inc. and Aligos Therapeutics, Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Aligos Therapeutics, Inc. are of similar size ($34.0M and $32.6M). ABVC BioPharma, Inc. grew revenue faster over the last twelve months: 5,035.4% against 893.0%. ABVC BioPharma, Inc. has the higher net margin (0.00% vs −241.0%) and the higher return on invested capital (−33.5% vs −3,379.3%). Across the 16 metrics below, ABVC BioPharma, Inc. leads on 10 and Aligos Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | ABVC | ALGS | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 100.00% | 65.16% |
| Operating margin | 0.00% | (250.63%) | 0.00% |
| Net margin | 0.00% | (241.01%) | 0.00% |
| Free cash flow margin | 0.00% | (299.90%) | 0.00% |
| Return on equity | (65.32%) | (113.59%) | (57.72%) |
| Return on assets | (39.88%) | (75.57%) | (49.22%) |
| Return on invested capital | (33.45%) | (3,379.28%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack